TFFP - TFF Pharmaceuticals Inc. (TFFP) CEO Glenn Mattes on Q4 2020 Results - Earnings Call Transcript

TFF Pharmaceuticals, Inc. (TFFP) Q4 2020 Earnings Conference Call March 10, 2021 04:30 PM ET Company Participants Paul Sagan - Investor Relations Glenn Mattes - President & Chief Executive Officer Dale Christensen - Director, Clinical Development Kirk Coleman - Chief Financial Officer Bill Williams - Professor, University of Texas, Austin Chris Cano - Chief Operating Officer Conference Call Participants Jonathan Aschoff - ROTH Capital Partners Boobalan Pachaiyappan - H.C. Wainwright Mayank Mamtani - B. Riley Securities Daniel Carlson - TW Research Group Bill Morrison - National Securities Presentation Operator Good afternoon ladies and gentlemen and welcome to the TFF Pharmaceuticals’ 2020 Financial Results Conference Call. As a reminder, this conference is being recorded. I would now turn the call over to your host, Mr. Paul Sagan of TFF Pharmaceuticals Investor Relations. You may begin your conference. Paul Sagan Thank you very much, operator. Hello, everyone and welcome to TFF Pharmaceuticals

For further details see:

TFF Pharmaceuticals, Inc. (TFFP) CEO Glenn Mattes on Q4 2020 Results - Earnings Call Transcript